High Fermentation Titer
Metabolic and regulatory modifications aim to significantly boost the specific productivity (mg}/\text{L}/\text{h) of the host strain.
Nisin is a widely used bacteriocin in the food industry, acting as a natural preservative (E number E234). Its application is currently limited by a low fermentation yield in the natural host ( Lactococcus lactis ) and a narrow antibacterial spectrum , primarily effective against Gram-positive bacteria. Expanding its functionality and increasing its cost-effectiveness are key goals for wider adoption.
CD Biosynsis offers a synthetic biology service focused on optimizing the production and function of Nisin. Our core strategy involves the metabolic regulation modification of Lactococcus lactis to enhance the flux of precursor amino acids and reduce competing metabolic pathways, thereby increasing Nisin synthesis. This is combined with domain engineering of the Nisin peptide to introduce modifications that may expand the antibacterial spectrum, including efficacy against some Gram-negative pathogens. This integrated approach aims to deliver a high-yield, broad-spectrum Nisin variant for the food and pharmaceutical sectors.
Get a QuoteImproving the industrial viability of Nisin requires addressing these production and functional limitations:
A successful solution must maximize the metabolic efficiency and engineer the peptide for expanded functionality.
CD Biosynsis utilizes advanced synthetic biology to enhance Nisin production and function:
Metabolic Regulation Modification of Lactococcus lactis
We employ genome editing to enhance the flux of key amino acid precursors (e.g., Serine and Threonine) and optimize energy metabolism to support higher synthesis rates.
Domain Engineering to Expand the Antibacterial Spectrum
We modify the Nisin peptide structure (e.g., N-terminus or specific hinge regions) to potentially increase hydrophobicity or charge, enabling it to better penetrate the outer membrane of Gram-negative bacteria.
Biosynthesis Machinery Optimization
We overexpress or modify the enzymes responsible for post-translational modification (e.g., NisB dehydratase, NisC cyclase) to eliminate folding and processing bottlenecks.
Self-Immunity System Tuning
We employ controlled expression of immunity genes to increase the host's tolerance to higher internal Nisin concentrations, supporting higher total production yield.
This systematic approach is focused on overcoming both the fermentation efficiency issues and the functional limitations of the natural Nisin peptide.
Our Nisin engineering service is dedicated to pursuing the following production goals:
High Fermentation Titer
Metabolic and regulatory modifications aim to significantly boost the specific productivity (mg}/\text{L}/\text{h) of the host strain.
Expanded Antibacterial Spectrum
Engineered variants are focused on showing efficacy against previously resistant Gram-negative bacteria , expanding market potential.
Enhanced Biosynthesis Efficiency
Optimization of post-translational machinery aims to ensure a higher conversion rate of the precursor peptide into active Nisin.
Natural and Safe Preservative
As a naturally derived bacteriocin, Nisin is a Generally Recognized as Safe (GRAS) substance, meeting strong consumer demand for clean labels.
Cost Reduction Potential
Higher fermentation yield is focused on reducing the overall cost per unit of active Nisin, improving competitiveness. [Image of Cost Reduction Icon]
We provide a biosynthetic platform aimed at maximizing the yield and functional spectrum of Nisin production.
Our Nisin strain engineering service follows a standardized, iterative research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and functional spectrum.
Explore the potential for a high-performance, broad-spectrum Nisin supply. CD Biosynsis provides customized strain and peptide engineering solutions:
How does Nisin work?
Nisin is a lanthionine-containing bacteriocin that kills bacteria primarily by binding to lipid II , a crucial cell wall precursor. This binding inhibits cell wall synthesis and allows the Nisin peptide to insert itself into the bacterial membrane, forming lethal pores .
Why is it generally only effective against Gram-positive bacteria?
Gram-negative bacteria possess a protective outer membrane that contains LPS (lipopolysaccharide). This membrane acts as an effective barrier, preventing the relatively large Nisin peptide from reaching its target, lipid II, in the inner membrane.
What is Domain Engineering for Nisin?
Domain engineering refers to making targeted changes to the peptide's amino acid sequence to alter its physicochemical properties (e.g., charge, hydrophobicity). The goal is often to create a variant that can disrupt or pass through the Gram-negative outer membrane while retaining its ability to bind lipid II.
What is the role of the Nisin immunity system?
The immunity system ensures the host L. lactis does not kill itself while producing Nisin. It involves membrane proteins that actively pump Nisin out of the cell and shield the inner membrane from Nisin binding, preventing autotoxicity.
What is the estimated project timeline?
A project involving metabolic regulation and domain engineering for spectrum expansion typically requires 20-24 weeks for final strain delivery and functional validation.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.